Item 4 of the Schedule 13D is hereby amended and supplemented as follows: Rollover Agreement Amendment On January 14, 2026, the Issuer entered into amendments to its existing Rollover and Support Agreements with certain stockholders of the Issuer, including Mr. Caring. Pursuant to the amendment to the Rollover and Support Agreement entered into by Mr. Caring (the "Rollover Agreement Amendment"), an additional 37,377 shares of Class A Common Stock and 4,113,833 shares of Class B Common Stock held by Mr. Caring are designated as "Rollover Shares" for purposes of the Merger Agreement and will remain outstanding immediately following the consummation of the Merger. The foregoing description of the Rollover Agreement Amendment does not purport to be complete, and is subject to, and qualified in its entirety by reference to, the full text of the Rollover Agreement Amendment, which is attached as an exhibit hereto and is incorporated by reference herein. Letter Agreement Amendment In addition, as disclosed in the Issuer's definitive proxy statement on Form DEFM14A filed with the SEC on December 11, 2025, Mr. Burkle and Mr. Jones entered into an amendment to the Letter Agreement on December 2, 2025 (the "Letter Agreement Amendment"), pursuant to which the parties revised the payment and settlement mechanics for the transactions contemplated by the Letter Agreement. The transaction contemplated by the Letter Agreement, as amended by the Letter Agreement Amendment, has not yet closed.